Challani Capital Faces Evaluation Shift Amid Strong Stock Performance and Profit Decline
Challani Capital, a microcap in the NBFC sector, has recently adjusted its evaluation, reflecting a change in stock trends. Despite a strong annual return of 71.46%, the company has faced an 8.7% profit decline. Key metrics indicate challenges, including a high Price to Book Value ratio and pledged promoter shares.
Challani Capital, a microcap player in the Non-Banking Financial Company (NBFC) sector, has recently undergone an adjustment in its evaluation. This revision reflects a shift in the technical trends associated with the stock, moving from a mildly bullish stance to a sideways position. In terms of key financial metrics, Challani Capital has demonstrated a notable return of 71.46% over the past year, significantly outperforming the broader market, which recorded a return of 10.88% during the same period. However, the company has faced challenges, including a decline in profits by 8.7% over the last year, despite the impressive stock return.
The stock is currently trading at a price of 26.49, with a 52-week high of 38.50 and a low of 14.51. Additionally, 53.35% of promoter shares are pledged, which could exert downward pressure on stock prices in a declining market. The average Return on Equity (ROE) stands at 9.76%, indicating weak long-term fundamental strength, while the valuation appears expensive with a Price to Book Value ratio of 6.
For more insights on Challani Capital's performance and evaluation, you can Discover the Latest Mojo Score and Financial Trend Performance - SignUp in less than 2 Minutes and get FREE Premium Access.
{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)
{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)
Related Stock Links
- {{stockdata.stock.stock_name.value}} Analysis
- {{stockdata.stock.stock_name.value}} Technicals
- {{stockdata.stock.stock_name.value}} Quality
- {{stockdata.stock.stock_name.value}} Valuation
- {{stockdata.stock.stock_name.value}} Financial Trend
- {{stockdata.stock.stock_name.value}} Return Analysis
- {{stockdata.stock.stock_name.value}} Price Analysis
- {{stockdata.stock.stock_name.value}} Quarterly Result Analysis
- {{stockdata.stock.stock_name.value}} Half-Yearly Result Analysis
- {{stockdata.stock.stock_name.value}} Nine Monthly Result Analysis
- {{stockdata.stock.stock_name.value}} Annual Results
- {{stockdata.stock.stock_name.value}} Balance Sheet
- {{stockdata.stock.stock_name.value}} Profit & Loss
- {{stockdata.stock.stock_name.value}} Cash Flow
- {{stockdata.stock.stock_name.value}} News
- {{stockdata.stock.stock_name.value}} Announcements
- {{stockdata.stock.stock_name.value}} Share Holding
- {{stockdata.stock.stock_name.value}} Peer Comparison
Our weekly and monthly stock recommendations are here
Loading...
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Target Price
{{sm.target_price }}
({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
₹{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
Most Read
